Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

ADPTADPT
Showing 8 of 29 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in Adaptive Biotechnologies Corp.

VIKING GLOBAL INVESTORS LP holds 30M shares of ADPT (Adaptive Biotechnologies Corp.), worth $643.4M as of 2026-Q2. ADPT represents 1.8% of VIKING GLOBAL INVESTORS LP's portfolio.

Current Value

$643.4M

Current Shares

30M

Total Value Change

+$489.8M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
30M
0.0%
$643.4M1.8%$21.45
0
2026-Q1
Unchanged
30M
0.0%
$416.3M1.2%$16.08
0
2025-Q4
Unchanged
30M
0.0%
$487.1M1.3%$16.42
0
2025-Q3
Unchanged
30M
0.0%
$448.7M1.2%$13.46
0
2025-Q2
Unchanged
30M
0.0%
$349.4M1.0%$11.79
0
2025-Q1
Unchanged
30M
0.0%
$222.9M0.7%$7.67
0
2024-Q4
Unchanged
30M
0.0%
$179.8M0.6%$6.11
0
2024-Q3
Unchanged
30M
0.0%
$153.6M0.6%$5.00
0

Other major holders of ADPT: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used